$MRNA AZN was essentially 8 days into phase 3, ran into a serious problem and restarted. They are way behind compared to MRNA which began 7/27 and has over 23K participants and no issues so far. In a little while, MRNA will complete the enrollment for all 30,000 cohorts. Positive phase 3 results will emerge and the stock will soar. R&D Day this Thursday may be an appropriate forum to provide incremental phase 3 update. Good time to load before the news comes out.
  • 8
8 Likes